FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805867498> ?p ?o ?g. }

• W2805867498 endingPage "2190" @default.
• W2805867498 startingPage "2190" @default.
• W2805867498 abstract "There are potential benefits and harms of hyperoxemia and hypoxemia for extremely preterm infants receiving more vs less supplemental oxygen.To compare the effects of different target ranges for oxygen saturation as measured by pulse oximetry (Spo2) on death or major morbidity.Prospectively planned meta-analysis of individual participant data from 5 randomized clinical trials (conducted from 2005-2014) enrolling infants born before 28 weeks' gestation.Spo2 target range that was lower (85%-89%) vs higher (91%-95%).The primary outcome was a composite of death or major disability (bilateral blindness, deafness, cerebral palsy diagnosed as ≥2 level on the Gross Motor Function Classification System, or Bayley-III cognitive or language score <85) at a corrected age of 18 to 24 months. There were 16 secondary outcomes including the components of the primary outcome and other major morbidities.A total of 4965 infants were randomized (2480 to the lower Spo2 target range and 2485 to the higher Spo2 range) and had a median gestational age of 26 weeks (interquartile range, 25-27 weeks) and a mean birth weight of 832 g (SD, 190 g). The primary outcome occurred in 1191 of 2228 infants (53.5%) in the lower Spo2 target group and 1150 of 2229 infants (51.6%) in the higher Spo2 target group (risk difference, 1.7% [95% CI, -1.3% to 4.6%]; relative risk [RR], 1.04 [95% CI, 0.98 to 1.09], P = .21). Of the 16 secondary outcomes, 11 were null, 2 significantly favored the lower Spo2 target group, and 3 significantly favored the higher Spo2 target group. Death occurred in 484 of 2433 infants (19.9%) in the lower Spo2 target group and 418 of 2440 infants (17.1%) in the higher Spo2 target group (risk difference, 2.8% [95% CI, 0.6% to 5.0%]; RR, 1.17 [95% CI, 1.04 to 1.31], P = .01). Treatment for retinopathy of prematurity was administered to 220 of 2020 infants (10.9%) in the lower Spo2 target group and 308 of 2065 infants (14.9%) in the higher Spo2 target group (risk difference, -4.0% [95% CI, -6.1% to -2.0%]; RR, 0.74 [95% CI, 0.63 to 0.86], P < .001). Severe necrotizing enterocolitis occurred in 227 of 2464 infants (9.2%) in the lower Spo2 target group and 170 of 2465 infants (6.9%) in the higher Spo2 target group (risk difference, 2.3% [95% CI, 0.8% to 3.8%]; RR, 1.33 [95% CI, 1.10 to 1.61], P = .003).In this prospectively planned meta-analysis of individual participant data from extremely preterm infants, there was no significant difference between a lower Spo2 target range compared with a higher Spo2 target range on the primary composite outcome of death or major disability at a corrected age of 18 to 24 months. The lower Spo2 target range was associated with a higher risk of death and necrotizing enterocolitis, but a lower risk of retinopathy of prematurity treatment." @default.
• W2805867498 created "2018-06-13" @default.
• W2805867498 creator A5001505718 @default.
• W2805867498 creator A5002587590 @default.
• W2805867498 creator A5010083380 @default.
• W2805867498 creator A5014034462 @default.
• W2805867498 creator A5019932110 @default.
• W2805867498 creator A5023506426 @default.
• W2805867498 creator A5026888938 @default.
• W2805867498 creator A5028307208 @default.
• W2805867498 creator A5029902617 @default.
• W2805867498 creator A5032318856 @default.
• W2805867498 creator A5033715797 @default.
• W2805867498 creator A5036600415 @default.
• W2805867498 creator A5037149980 @default.
• W2805867498 creator A5038662782 @default.
• W2805867498 creator A5040294264 @default.
• W2805867498 creator A5041821959 @default.
• W2805867498 creator A5042556466 @default.
• W2805867498 creator A5045743294 @default.
• W2805867498 creator A5049709255 @default.
• W2805867498 creator A5053788765 @default.
• W2805867498 creator A5060253455 @default.
• W2805867498 creator A5063657135 @default.
• W2805867498 creator A5065080507 @default.
• W2805867498 creator A5067892579 @default.
• W2805867498 creator A5074205350 @default.
• W2805867498 creator A5077036936 @default.
• W2805867498 creator A5077886902 @default.
• W2805867498 creator A5078716321 @default.
• W2805867498 creator A5090204853 @default.
• W2805867498 date "2018-06-05" @default.
• W2805867498 modified "2023-10-16" @default.
• W2805867498 title "Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration" @default.
• W2805867498 cites W1480209957 @default.
• W2805867498 cites W1974882914 @default.
• W2805867498 cites W1983671704 @default.
• W2805867498 cites W1990808748 @default.
• W2805867498 cites W1996644321 @default.
• W2805867498 cites W1998726711 @default.
• W2805867498 cites W2022916613 @default.
• W2805867498 cites W2040068497 @default.
• W2805867498 cites W2050602851 @default.
• W2805867498 cites W2064357794 @default.
• W2805867498 cites W2071886528 @default.
• W2805867498 cites W208036677 @default.
• W2805867498 cites W2085166307 @default.
• W2805867498 cites W2098931866 @default.
• W2805867498 cites W2106356304 @default.
• W2805867498 cites W2125435699 @default.
• W2805867498 cites W2131611604 @default.
• W2805867498 cites W2131920995 @default.
• W2805867498 cites W2141472583 @default.
• W2805867498 cites W2142493194 @default.
• W2805867498 cites W2155924336 @default.
• W2805867498 cites W2161729359 @default.
• W2805867498 cites W2163724055 @default.
• W2805867498 cites W2202692369 @default.
• W2805867498 cites W2210128369 @default.
• W2805867498 cites W2232562478 @default.
• W2805867498 cites W2337429578 @default.
• W2805867498 cites W2487756862 @default.
• W2805867498 cites W2573710142 @default.
• W2805867498 cites W2589903002 @default.
• W2805867498 cites W3038617264 @default.
• W2805867498 cites W4293241248 @default.
• W2805867498 doi "https://doi.org/10.1001/jama.2018.5725" @default.
• W2805867498 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6583054" @default.
• W2805867498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29872859" @default.
• W2805867498 hasPublicationYear "2018" @default.
• W2805867498 type Work @default.
• W2805867498 sameAs 2805867498 @default.
• W2805867498 citedByCount "265" @default.
• W2805867498 countsByYear W28058674982018 @default.
• W2805867498 countsByYear W28058674982019 @default.
• W2805867498 countsByYear W28058674982020 @default.
• W2805867498 countsByYear W28058674982021 @default.
• W2805867498 countsByYear W28058674982022 @default.
• W2805867498 countsByYear W28058674982023 @default.
• W2805867498 crossrefType "journal-article" @default.
• W2805867498 hasAuthorship W2805867498A5001505718 @default.
• W2805867498 hasAuthorship W2805867498A5002587590 @default.
• W2805867498 hasAuthorship W2805867498A5010083380 @default.
• W2805867498 hasAuthorship W2805867498A5014034462 @default.
• W2805867498 hasAuthorship W2805867498A5019932110 @default.
• W2805867498 hasAuthorship W2805867498A5023506426 @default.
• W2805867498 hasAuthorship W2805867498A5026888938 @default.
• W2805867498 hasAuthorship W2805867498A5028307208 @default.
• W2805867498 hasAuthorship W2805867498A5029902617 @default.
• W2805867498 hasAuthorship W2805867498A5032318856 @default.
• W2805867498 hasAuthorship W2805867498A5033715797 @default.
• W2805867498 hasAuthorship W2805867498A5036600415 @default.
• W2805867498 hasAuthorship W2805867498A5037149980 @default.
• W2805867498 hasAuthorship W2805867498A5038662782 @default.
• W2805867498 hasAuthorship W2805867498A5040294264 @default.
• W2805867498 hasAuthorship W2805867498A5041821959 @default.
• W2805867498 hasAuthorship W2805867498A5042556466 @default.
• W2805867498 hasAuthorship W2805867498A5045743294 @default.

• next